The future of kinesin research in cancer looks promising with ongoing efforts to develop more specific and potent inhibitors. Advances in molecular biology and genomics are expected to uncover new insights into the role of kinesins in cancer. This could lead to the identification of novel therapeutic targets and more personalized approaches to cancer treatment.
